Whitehawk Therapeutics, Inc. WHWK
Set alert
3.12 USD -0.12 -3.70%
At close · Nov 2
3.12 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
3.08 Day range 3.30
1.97 52-week range 5.50
- YTD
- +28.93%
- 1 year
- +30.00%
- Open
- 3.27
- Prev close
- 3.24
- Mkt cap
- 177.87M
- Vol
- 216.11K
- Avg vol
- 346.38K
- EPS
- -1.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.08
- High
- 3.30
2Y chart
Signals (89)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
Newest 20 of 89.
Financials — quick view
WHWK Revenue — quarterly 0
WHWK Net income — quarterly -16.64M
WHWK EPS — quarterly -0.20
News
- Surrozen (NASDAQ:SRZN) & Whitehawk Therapeutics (NASDAQ:WHWK) Financial Comparison
- Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Stock Has Consensus Target Price of $8.33 According to Brokerages
- Whitehawk Therapeutics Presents Two-Real World Analyses Supporting Mucin 16
- Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
- Stifel Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $9
- Analysts Set Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Price Target at $8.20
- Whitehawk Therapeutics, Inc. (WHWK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Reported Sunday, Whitehawk's Real-World Data Show PTK7 Expression Remains Stable After Standard-Of-Care Therapies, Reinforcing Rationale For HWK-007 In EGFR Wild-Type NSCLC
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
Your note
Sign in to keep a note on WHWK — it syncs with the Stock Master app.